Mayflower Financial Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Mayflower Financial Advisors, LLC holds 23 biotech & pharma companies tracked by BioSniper, totaling $30.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
23
Total value held
$30.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 23,517 | $5.7M |
| ABBVAbbVie Inc. | 20,303 | $4.4M |
| LLYELI LILLY & Co | 3,777 | $3.5M |
| PMPhilip Morris International Inc | 15,183 | $2.5M |
| MRKMerck & Co., Inc. | 18,836 | $2.3M |
| ABTABBOTT LABORATORIES | 16,755 | $1.7M |
| PFEPFIZER INC | 56,399 | $1.6M |
| NVSNovartis AG | 8,726 | $1.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 4,402 | $1.2M |
| AMGNAMGEN INC | 3,372 | $1.2M |
| CORCencora Inc. | 2,829 | $889K |
| GILDGILEAD SCIENCES, INC. | 6,132 | $855K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,751 | $782K |
| BMYBRISTOL MYERS SQUIBB CO | 7,959 | $483K |
| GMOptec International, Inc. | 4,644 | $346K |
| IDXXIDEXX LABORATORIES INC /DE | 570 | $320K |
| AZNASTRAZENECA PLC | 1,222 | $237K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,760 | $208K |
| GLUEMonte Rosa Therapeutics, Inc. | 10,000 | $165K |
| ELTXElicio Therapeutics, Inc. | 10,000 | $107K |
| IBRXImmunityBio, Inc. | 10,212 | $78K |
| HELPCYBIN INC. | 10,290 | $49K |
| INOINOVIO PHARMACEUTICALS, INC. | 12,559 | $22K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.